Hypophosphatemic rickets.

Area of Science:

• Endocrinology
• Genetics
• Metabolic Disorders

Background:

• Hypophosphatemic rickets (HR) is a group of inherited disorders characterized by impaired phosphate reabsorption.
• Fibroblast growth factor 23 (FGF23) plays a crucial role in phosphate and vitamin D metabolism.
• Genetic mutations affecting FGF23 or its signaling pathway are primary causes of various HR subtypes.

Purpose of the Study:

• To review recent advances in understanding the regulation of phosphate metabolism in HR.
• To describe the genetic basis of different forms of HR.
• To explore novel therapeutic strategies for patients with HR.

Main Methods:

• Literature review of recent studies on hypophosphatemic rickets.
• Analysis of genetic mutations associated with X-linked, autosomal recessive, and autosomal dominant HR.
• Evaluation of current and emerging treatment approaches.

Main Results:

• FGF23 overproduction is identified as a potential primary cause of HR.
• Specific gene mutations (PHEX, DMP1, ENPP1, FGF23) are linked to distinct HR subtypes.
• Current treatments (activated vitamin D, phosphate salts) show variable efficacy, with some patients exhibiting poor response.
• Iron deficiency may influence the phenotype of autosomal dominant HR by affecting FGF23 production.

Conclusions:

• Identifying causative mutations aids in HR diagnosis and prognosis.
• Targeting FGF23 overproduction with neutralizing antibodies represents a promising future therapeutic strategy for FGF23-dependent HR.